More tools:Markets·Screener·Research·Chat

LifeStance Health Group, Inc. Common Stock (LFST) Financial Statements

LifeStance Health Group, Inc. Common Stock
SIC 8000 · SERVICES-HEALTH SERVICES
FIGI BBG01138DHT2
XNAS · usd
12.80▲ 0.07 (0.55%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close12.73
Day's Range12.49 – 12.91
52-Week Range4.77 – 13.15
Volume3.1M
Avg Volume3.9M
Share Statistics
Shares Outstanding
Employees8,040
ExchangeXNAS
Listed2021-06-10
Share count as of July 29, 2026
Loading Income Statement…
Key questions about LifeStance Health Group, Inc. Common Stock (LFST)
What is LifeStance Health Group, Inc. Common Stock's Market Cap?
LifeStance Health Group, Inc. Common Stock's Market Cap is $4.9B, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Enterprise Value?
LifeStance Health Group, Inc. Common Stock's Enterprise Value is $4.9B, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Trailing P/E?
LifeStance Health Group, Inc. Common Stock's Trailing P/E is 96.6×, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Price / Sales?
LifeStance Health Group, Inc. Common Stock's Price / Sales is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's EV / Revenue?
LifeStance Health Group, Inc. Common Stock's EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's EV / EBITDA?
LifeStance Health Group, Inc. Common Stock's EV / EBITDA is 40.7×, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Revenue (TTM)?
LifeStance Health Group, Inc. Common Stock's Revenue (TTM) is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Net Income (TTM)?
LifeStance Health Group, Inc. Common Stock's Net Income (TTM) is $50.6M, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's EBITDA?
LifeStance Health Group, Inc. Common Stock's EBITDA is $120.8M, based on as-reported figures from SEC (XBRL) filings.
What is LifeStance Health Group, Inc. Common Stock's Diluted EPS (TTM)?
LifeStance Health Group, Inc. Common Stock's Diluted EPS (TTM) is 0.13, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
TOTAL REVENUE
YoY growth+26.1%+21.2%+17.4%+16.3%
OPERATING EXPENSES
Center costs, excluding depreciation and amortization shown separately below
General and administrative expenses
Depreciation and amortization
Total operating expenses
% of revenue93.0%94.5%95.3%98.0%
INCOME (LOSS) FROM OPERATIONS
% of revenue7.0%5.5%4.7%2.0%
OTHER EXPENSE
Loss on remeasurement of contingent
Transaction costs
Interest expense, net
Other expense
Total other expense
INCOME (LOSS) BEFORE INCOME TAXES
INCOME TAX (PROVISION) BENEFIT
NET INCOME (LOSS)—
% of revenue5.4%—3.1%0.3%
Net Income
% of revenue5.4%3.5%3.1%0.3%